Petition to the DEA and FDA to Reschedule the Opioid Tramadol From Schedule IV to Schedule II

View as PDF

View Press Release

Public Citizen petitioned the Drug Enforcement Administration and Food and Drug Administration (FDA) to reschedule the opioid tramadol from the weakly controlled schedule IV under the Controlled Substances Act to the more tightly controlled schedule II because it is overprescribed, often misused, highly addictive and potentially deadly.

November 7, 2019, FDA acknowledgment letter.

January 17, 2020, DEA letter accepting petition for filing.

May 4, 2020, FDA interim response letter.

May 28, 2020, supplement to the petition to the DEA and FDA to reschedule tramadol.

See Public Citizen’s other work on opioid drug issues.